About
20/20 BioLabs develops and commercializes AI-powered blood tests for the early detection and prevention of multiple cancers and chronic diseases using novel biomarker approaches and painless home collection devices.
Explore 20/20 BioLabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.